NYSE:CORHealthcare
A Look At Cencora (COR) Valuation After 2026 Guidance Update And New CAR T Distribution Deal
Cencora (COR) is back on investors’ radar after updating its fiscal 2026 outlook, raising adjusted EPS expectations while projecting lower revenue growth, along with a new CAR T distribution agreement with Kite, a Gilead Company.
See our latest analysis for Cencora.
The updated fiscal 2026 guidance and CAR T agreement appear to have helped the share price regain some ground in the short term, with a 1 month share price return of 5.35%. However, momentum has cooled, with a 3 month share price...